🇺🇸 FDA
Pipeline program

Methadone

999904390

Phase 1 small_molecule completed

Quick answer

Methadone for Opiate-Related Disorders is a Phase 1 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Opiate-Related Disorders
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials